DexCom's expanding CGM market, G7 rollout, and global growth momentum position it for gains, despite pricing pressure and ...
Over the last six months, DexCom’s shares have sunk to $62.07, producing a disappointing 6.4% loss - a stark contrast to the ...
Dexcom develops continuous glucose monitoring (CGM) devices. Diabetic patients use these to track their glucose levels in ...
ETHealthworld.com brings latest blood glucose levels news, views and updates from all top sources for the Indian Health industry.
Montana Joyce is lacing up to give back to the organization that changed her brother's life.
April 16 (Reuters) - Abbott cut its full-year profit forecast on Thursday due to a 20 cent-per-share hit from its recent $23 ...
CEO Robert B. Ford remains optimistic about the company's opportunity in the continuous glucose monitor (CGM) market.
Continuous glucose monitoring metrics may be able to predict future glycemic trajectories for children and adolescents with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results